Lidereau, Rosette
Institut Curie,
France
2025 Rank: 117348
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 4448 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117348 | 122924 |
| Total Cites | 20608 | 23255 |
| H-index | 69 | 74 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 171 | 190 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3785 | 4156 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18331 | 20048 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.16 |
| Self-Citation Percentage |
11.38%
|
|
Lidereau, Rosette
Institut Curie,
France
2024 Rank: 108263
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 4181 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108263 | 114929 |
| Total Cites | 19899 | 22511 |
| H-index | 69 | 74 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 170 | 189 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3739 | 4109 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17681 | 19370 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.60%
|
|
Lidereau, Rosette
Institut Curie,
France
2023 Rank: 101342
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 3982 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101342 | 107586 |
| Total Cites | 19101 | 21672 |
| H-index | 68 | 73 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 168 | 187 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3670 | 4035 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16942 | 18603 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.16 |
| Self-Citation Percentage |
11.86%
|
|
Lidereau, Rosette
Institut Curie,
France
2022 Rank: 93628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 3711 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93628 | 99007 |
| Total Cites | 18167 | 20652 |
| H-index | 66 | 71 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 165 | 184 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3594 | 3953 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16091 | 17689 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
12.03%
|
|
Lidereau, Rosette
Institut Curie,
France
2021 Rank: 88872
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 3555 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88872 | 94424 |
| Total Cites | 17630 | 20059 |
| H-index | 66 | 70 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 163 | 181 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3539 | 3892 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15614 | 17184 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
12.11%
|
|
Lidereau, Rosette
Institut Curie,
France
2020 Rank: 81935
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Genetics & Heredity
Rank in SubField 1: 3462 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81935 | 86730 |
| Total Cites | 16454 | 18732 |
| H-index | 63 | 69 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 163 | 181 |
| Number of Single+First+Last Authored Papers | 121 | 121 |
| Total Cites to Single+First+Last Authored Papers | 3453 | 3795 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14525 | 16005 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
12.16%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.